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The response to DNA damage, which regulates
nuclear processes such as DNA repair, transcription,
and cell cycle, has been studied thoroughly. How-
ever, the cytoplasmic response to DNA damage is
poorly understood. Here, we demonstrate that DNA
damage triggers dramatic reorganization of the
Golgi, resulting in its dispersal throughout the cyto-
plasm. We further show that DNA-damage-induced
Golgi dispersal requires GOLPH3/MYO18A/F-actin
and the DNA damage protein kinase, DNA-PK. In
response to DNA damage, DNA-PK phosphorylates
GOLPH3, resulting in increased interaction with
MYO18A, which applies a tensile force to the Golgi.
Interference with the Golgi DNA damage response
by depletion of DNA-PK, GOLPH3, or MYO18A
reduces survival after DNA damage, whereas over-
expression of GOLPH3, as is observed frequently
in human cancers, confers resistance to killing by
DNA-damaging agents. Identification of the DNA-
damage-induced Golgi response reveals an unex-
pected pathway through DNA-PK, GOLPH3, and
MYO18A that regulates cell survival following DNA
damage.
INTRODUCTION
DNA damage is well known to trigger the activation of DNA
repair, cell-cycle arrest, and transcriptional changes. These
nuclear effects of DNA damage have been studied extensively
(Ciccia and Elledge, 2010; Lord and Ashworth, 2012; Morandell
and Yaffe, 2012). By contrast, little is known regarding the
regulation of cytoplasmic organelles, such as the Golgi, in
response to DNA damage. Our studies, described here, of
the regulation of the Golgi protein GOLPH3 (also known as
GMx33, GPP34, and yeast Vps74p; Bell et al., 2001; Schmitz
et al., 2008; Snyder et al., 2006; Tu et al., 2008; Wu et al.,
2000) identify a direct signaling pathway initiated by DNA
damage that leads to dramatic reorganization of the Golgi.
We previously demonstrated that GOLPH3 is an effector of
PtdIns(4)P that links trans-Golgi membranes to the unconven-tional myosin MYO18A and to the actin cytoskeleton (Dippold
et al., 2009). We found that the PtdIns(4)P/GOLPH3/MYO18A/
F-actin pathway applies a tensile force to the Golgi, stretching
the Golgi ribbon around the nucleus and promoting vesicle
exit from the Golgi (Bishe´ et al., 2012; Dippold et al., 2009;
Ng et al., 2013). Unexpectedly, unbiased screening identified
GOLPH3 as an oncogene that is amplified in human cancers
(Scott et al., 2009), and GOLPH3 overexpression occurs
frequently and has negative prognostic significance in several
cancers (Hu et al., 2013; Hua et al., 2012; Kunigou et al., 2011;
Li et al., 2012, 2011; Wang et al., 2012; Zeng et al., 2012; Zhou
et al., 2012).
Here, we demonstrate that in mammalian cells, DNA damage
triggers the Golgi to fragment and disperse throughout the
cytoplasm. This response requires the direct phosphorylation
of GOLPH3 on T143/T148 by DNA-PK, resulting in enhanced
interaction between GOLPH3 and MYO18A. Thus, we show
that common cancer therapeutic agents, by triggering DNA
damage, activate GOLPH3, a proven oncogene. We find that
the DNA-PK/GOLPH3/MYO18A pathway is required for normal
survival following DNA damage. Furthermore, overexpression
of GOLPH3 confers resistance to killing by DNA-damaging
agents. Thus, we identify a novel pathway that is activated by
DNA damage and signals directly to the Golgi, with important
consequences for the cellular response to chemotherapeutic
agents.
RESULTS
DNA Damage Causes Dispersal of the Golgi
GOLPH3 has been shown to be a phosphoprotein (Wu et al.,
2000), although the sites of phosphorylation were previously
unidentified. Using large-scale immunoprecipitation (IP) of
GOLPH3 followed by mass spectrometry, we observe that
T143 and T148 are phosphorylated together on GOLPH3
(Figure 1A). We note that T143 is followed by a glutamine at
the +1 position, thereby comprising a ‘‘TQ’’ motif that is highly
conserved among vertebrate GOLPH3 orthologs. TQ/SQ is
the preferred substrate motif for phosphorylation by the DNA-
damage-activated protein kinases ATM, ATR, and DNA-PK
(Kim et al., 1999; O’Neill et al., 2000). Interestingly, TVQ at
T148 also conforms to an alternate preferred substrate motif
for ATM and DNA-PK (Anderson, 1993; O’Neill et al., 2000;
Obenauer et al., 2003).Cell 156, 413–427, January 30, 2014 ª2014 Elsevier Inc. 413
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Figure 1. DNA Damage Triggers Golgi Dispersal
(A) Amino acid sequence alignment reveals evolutionary conservation of T143, T148, and the ‘‘TQ’’ motif in GOLPH3. Genomes of organisms listed below the
line lack a DNA-PK gene.
(B) Dose response of Golgi to DNA damage. HEK293 cells treated with the indicated doses of CPT or DOXO for 24 hr, or by IR followed by 24 hr of recovery
were fixed and stained for GM130 (cis-Golgi) and DAPI (DNA).
(C and D) Golgi area per cell was measured relative to control. For each point, nR 21, pooled from three experiments.
In this and all subsequent figures, graphs indicate mean ± SEM, with statistical significance shown (t test). See also Figure S1.
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Because little was known regarding the effects of DNA dam-
age on the Golgi, and because of GOLPH3’s role in maintaining
Golgi shape, we examined whether DNA damage affects
Golgi morphology. We treated human embryonic kidney 293
(HEK293) cells with camptothecin (CPT), doxorubicin (DOXO),
or ionizing radiation (IR) to induce DNA damage. Exposure to
each treatment caused Golgi morphology to change dramati-
cally from the usual perinuclear ribbon to punctate fragments
dispersed throughout the cytoplasm (Figure 1B; Movies S1
and S2 available online). We quantified Golgi dispersal by
measuring the Golgi area per cell, which significantly increased
as doses of CPT, DOXO, and IR increased (Figures 1C and
1D). Even low doses of DNA-damaging agents that caused little
or no apparent cytotoxicity caused significant Golgi dispersal.
Golgi dispersal in response to DNA damage occurred in many
cell lines (HEK293, HeLa, NRK, MCF7, and MDA-MB-231), as
well as in primary mouse embryonic fibroblasts, primary mouse
hepatocytes, and primary human umbilical vein endothelial cells
(HUVECs) (Figures 1B–1D, S1A–S1H, S3D, and S3E; data not
shown). Thus, Golgi dispersal is a common feature of the DNA
damage response in mammalian cells.
We further analyzed the kinetics of Golgi dispersal after DNA
damage. As shown in Figure 2A and Movies S1 and S2, in
HeLa cells dispersal of the Golgi was detectable within 4 hr
after treatment with DNA-damaging agents and progressively
increased over 24 hr. Long-time-course experiments in which
HeLa cells were treated with DOXO for 24 hr, followed by drug
washout, revealed that the most dramatic Golgi dispersal per-
sisted for at least 5 days (Figure S2A). Moreover, the Golgi
remained detectably dispersed at least 30 days after the initial
DNA damage occurred (Figure 2B), at a time when cell prolifera-
tion has completely recovered (van Vugt and Yaffe, 2010).
Although the Golgi dispersed in response to DNA damage,
it remained intact, as markers for the cis-Golgi (GM130),
medial-Golgi (a-mannosidase II [ManII]), and trans-Golgi (p230,
GOLPH3, and TGN46) all remained colocalized (Figures 3A,
4A, 5A, 6A, S1A, and S5A). We compared the Golgi localization
of EYFP-FAPP1-PH, a reporter for PtdIns(4)P (Dippold et al.,
2009; Godi et al., 2004), before versus after treatment with
DNA-damaging agents (Figures S1I and S1J). We did not
observe qualitative or quantitative changes, arguing that
PtdIns(4)P levels at the Golgi are unchanged by DNA damage.
The dispersed Golgi remained distinct from other punctate
organelles, as shown by a lack of colocalization with markers
for early endosomes or lysosomes (Figures S2B and S2C).
Notably, these other organelles appeared to be unchanged by
DNA damage.
DNA-Damage-Induced Golgi Dispersal Occurs
Independently of Apoptosis
We next examined candidate mechanisms of DNA-damage-
induced Golgi dispersal. Since changes in Golgi morphology
have been reported to occur during apoptosis (Chiu et al.,
2002; Jung et al., 2006; Lane et al., 2002; Mancini et al.,
2000; Qian and Yang, 2009), we examined whether DNA-dam-
age-induced Golgi dispersal occurs as a consequence of
apoptosis. Although treatment with CPT caused a significant
increase in the number of apoptotic cells (Figures 2C and2D), still only a small fraction of cells became apoptotic
(1.74% ± 0.08% [mean ± SEM] positive for cleaved caspase-
3 (CCasp-3), coinciding with other morphological evidence of
apoptosis, such as pyknotic nuclei, fragmented nuclei, or
plasma membrane [PM] blebbing). The Golgi in these apoptotic
cells do exhibit abnormal morphology, as expected. By
contrast, the nonapoptotic cells, which constitute the majority
of cells, display a uniformly dispersed Golgi. The addition of
an apoptosis inhibitor, zVAD-fmk, significantly decreased the
number of apoptotic cells produced in response to CPT,
without impeding the dispersal of the Golgi (Figure 2D), indi-
cating that Golgi dispersal following DNA damage occurs
independently of apoptosis.
Long-time-course time-lapse imaging shows that cells with a
dispersed Golgi after DNA damage remained alive and healthy,
without any morphological evidence of apoptosis, during at least
17 hr of follow-up imaging (Movies S1 and S2). Likewise, days
to weeks following low doses of DNA-damaging agents, at
times when the cells had otherwise completely recovered, we
observed persistent changes in Golgi morphology (Figures 2B
and S2A). Taken together, these results indicate that DNA-
damage-induced dispersal of the Golgi occurs independently
of apoptosis.
DNA-Damage-Induced Golgi Dispersal Is Unlike
Microtubule Depolymerization
Depolymerization of microtubules by nocodazole is known to
cause Golgi dispersal (Thyberg and Moskalewski, 1999). There-
fore, we examined whether Golgi dispersal in response to DNA
damage appears similar to the response to nocodazole treat-
ment and hence might be mechanistically related. Microtubule
depolymerization produces a dispersed Golgi that is closely
apposed to the transitional endoplasmic reticulum (tER; Ham-
mond and Glick, 2000). When HeLa cells were treated with
nocodazole for 1 hr, we observed Golgi dispersal and its
association with Sec31A, a marker of the tER (Figure S2D).
By contrast, after DNA damage, the dispersed Golgi remained
independent of the tER. Moreover, addition of nocodazole after
CPT resulted in further Golgi reorganization, with association
with the tER. Quantification of Golgi dispersal induced by
nocodazole, DNA damage, or the combination of the two
demonstrated an additive effect of combining the two
treatments (Figure S2E). Thus, DNA-damage-induced Golgi
dispersal is mechanistically distinct from the dispersal induced
by nocodazole.
We also considered whether the dispersal of the Golgi after
DNA damage might be a consequence of cell-cycle arrest in
early mitosis, when the Golgi normally fragments (Wei and
Seemann, 2009). However, consistent with published data
(Hennequin et al., 1994; Hsiang et al., 1989; Maney et al.,
2011), HeLa cells and HUVECs treated with CPT arrested in
G1 or early S phase (Figures S2F and S2G; see also Movie S2),
part of the cell cycle during which the Golgi generally remains
intact. Furthermore, long-time-course experiments demon-
strated persistence of Golgi dispersal even after cell proliferation
had recovered (Figures 2B and S2A). We conclude that arrest
in M phase is not the mechanism of DNA-damage-induced
Golgi dispersal.Cell 156, 413–427, January 30, 2014 ª2014 Elsevier Inc. 415
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Figure 2. DNA-Damage-Induced Golgi Dispersal Occurs Rapidly, Is Persistent, and Is Independent of Apoptosis
(A) DNA-damage-induced Golgi dispersal in HeLa is detectable within 4 hr and progressively increases over 24 hr. For each treatment, p < 0.03 (t test) versus
control for all time points after 4 hr; nR 18 per point, pooled from three experiments. See also time-lapse imaging in Movies S1 and S2.
(B) DNA-damage-induced Golgi dispersal in HeLa is detectable 1 month after treatment with 16–62.5 nM DOXO for 24 hr (shaded). Each concentration of
DOXO causes significant Golgi dispersal versus corresponding DMSO-treated cells on each day examined (p < 0.01, t test); n R 29 per point; pooled from
two experiments.
(C) HeLa treated with 2 mM CPT or DMSO (control) for 24 hr were stained with the indicated antibodies and DAPI (DNA).
(D) HeLa treated as in (C), but also with zVAD-fmk to inhibit apoptosis. Graphed are the relative Golgi area (top) and number of apoptotic cells (bottom), with
the number of cells indicated (n); pooled from three experiments.
See also Figure S2.
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GOLPH3, MYO18A, and F-actin Are All Required for
DNA-Damage-Induced Golgi Dispersal
Because of the important role of GOLPH3/MYO18A/F-actin in
the maintenance of Golgi morphology (Dippold et al., 2009; Ng
et al., 2013) and the presence of a phospho-TQ site in GOLPH3,
we tested whether GOLPH3 and MYO18A are required for
DNA-damage-induced dispersal of the Golgi. We depleted
GOLPH3 or MYO18A approximately 90% after transient trans-
fection of each of three different small interfering RNA (siRNA)
oligos (Figures S3A and S3B). Depletion of GOLPH3 or
MYO18A in HeLa cells prevented Golgi dispersal in response
to DNA damage (Figures 3A–3C). Similar results were observed
in HEK293 and HUVECs (Figures S3C–S3E). Depletion of
GOLPH3 or MYO18A did not inhibit the overall DNA damage
response, as DNA damage foci still formed in response to
DNA-damaging agents in the knockdown cells (Figure S3F).
Since F-actin links to MYO18A and is also required for mainte-
nance of normal Golgi morphology (Dippold et al., 2009; La´zaro-
Die´guez et al., 2006), we determined whether F-actin is required
for Golgi dispersal after DNA damage. As shown in Figures 3D,
3E, and Movie S3, depolymerization of F-actin led to rapid
reversal of DNA-damage-induced Golgi dispersal. Therefore,
GOLPH3, MYO18A, and F-actin are all required for DNA-dam-
age-induced dispersal of the Golgi.
Phosphorylation of the TQ Motif in GOLPH3 Is Required
for DNA-Damage-Induced Golgi Dispersal
We next asked whether phosphorylation of GOLPH3 on the
TQ site at T143 and the adjacent T148 is required for DNA-
damage-induced dispersal of the Golgi. We mutated T143 and
T148 in an siRNA-resistant GOLPH3 mammalian expression
construct (wild-type [WT] sequence: TQ-TVQ) to create an un-
phosphorylatable mutant (AQ-AVQ) and two phosphomimetic
mutants (EQ-EVQ and DQ-DVQ). We then depleted endogenous
GOLPH3 protein by siRNA and expressed siRNA-resistant WT
or mutant GOLPH3. As described previously, knockdown of
GOLPH3 resulted in a compact Golgi morphology (Dippold
et al., 2009; Ng et al., 2013). In the absence of DNA damage,
expression of each mutant or WT protein rescued the normal
extended ribbon morphology of the Golgi (Figures S4A–S4C).
All mutants localized to the Golgi and all bound strongly to
PtdIns(4)P (Figures S4D and S4E). Restoration of GOLPH3
protein levels with WT or either phosphomimetic mutant
rescued the dispersal after DNA damage (Figures 4A and 4B).
By contrast, although the unphosphorylatable mutant rescued
extended Golgi morphology in the absence of DNA damage, it
failed to rescue DNA-damage-induced dispersal of the Golgi.
We conclude that phosphorylation of T143/T148 on GOLPH3 is
necessary (although alone is not sufficient) for DNA-damage-
induced Golgi dispersal.
DNA-PK Is Required for Golgi Dispersal after DNA
Damage
Because phosphorylation of GOLPH3 on T143/T148 is required
for DNA-damage-induced Golgi dispersal, we sought to identify
the responsible kinase. The twomain kinases that phosphorylate
TQ or SQ motifs and are activated in response to double-
stranded DNA breaks are ATM and DNA-PK (Ciccia and Elledge,2010; O’Neill et al., 2000). We treated cells with inhibitors
specific for ATM (KU55933; Hickson et al., 2004) or DNA-PK
(NU7441; Tavecchio et al., 2012) and analyzedGolgi morphology
after DNA damage. Treatment with KU55933 minimally pre-
vented Golgi dispersal in response to DNA damage by CPT or
IR, whereas treatment with NU7441 completely prevented
DNA-damage-induced dispersal of the Golgi (Figures S5A–S5C).
We further tested a requirement for ATM using ATM-deficient
A-T fibroblasts derived from a patient with ataxia telangiectasia.
In parallel, we examined A-T fibroblasts that were reconstituted
with ATM. In A-T cells with or without reconstitution of ATM,
the Golgi dispersed similarly after DNA damage. In these cells,
treatment with KU55933 had little effect, whereas NU7441 again
completely prevented DNA-damage-induced dispersal of the
Golgi (Figures 5A–5C). We conclude that ATM is not required
for DNA-damage-induced dispersal of the Golgi.
To confirm whether DNA-PK is required for DNA-damage-
induced dispersal of the Golgi, we utilized siRNA knockdown
of DNA-PK. Depletion of DNA-PK by either of two specific
siRNAs (Figure S6A) prevented Golgi dispersal in response to
DNA damage in HeLa (Figures 6A and 6B), HEK293 (Figure S3C),
and HUVECs (Figure S3E). Therefore, DNA-PK, but not ATM, is
required for DNA-damage-induced Golgi dispersal.
The DNA-PK kinase inhibitor also allowed us to test whether
DNA-PK kinase activity is required to maintain Golgi dispersal
after DNA damage. We treated cells with DOXO to cause
dispersal of the Golgi. Addition of NU7441 caused a dramatic
reversal of the Golgi dispersal (Movie S4). Thus, continuous
DNA-PK kinase activity is necessary to maintain Golgi dispersal
following DNA damage.
We also examined whether the related protein kinases ATR
and mTOR might have a role in DNA-damage-induced Golgi
dispersal. Although inhibition of DNA-PK significantly reversed
Golgi dispersal, inhibition of ATR with VE821 (Charrier et al.,
2011) or mTOR with Torin1 (Liu et al., 2010) did not (Figure S5D).
We conclude that DNA-PK, but not the related kinases ATM,
ATR, and mTOR, is specifically required for DNA-damage-
induced Golgi dispersal.
DNA-PK Directly Phosphorylates GOLPH3
Because the T143 and T148 phosphorylation sites in GOLPH3
conform to the preferred and alternative substrate motifs for
DNA-PK, we asked whether DNA-PK directly phosphorylates
GOLPH3. First, we determined whether DNA-PK is capable of
directly phosphorylating GOLPH3. Using an in vitro kinase
assay, we observed that purified DNA-PK could directly phos-
phorylate glutathione S-transferase (GST)-GOLPH3 expressed
and purified from E. coli (Figure 6C). This phosphorylation
occurred on T143 and/or T148, as the AQ-AVQ mutation largely
abolished it. Furthermore, we verified that the responsible
kinase in the commercially obtained DNA-PK preparation is
actually DNA-PK because the phosphorylation is completely
eliminated by NU7441.
We next examined whether DNA-PK is directly responsible
for GOLPH3 phosphorylation in vivo. The DNA-PK preferred
phosphorylation motif requires the Q at the +1 position (O’Neill
et al., 2000), whereas most other kinases have different
sequence requirements (Mok et al., 2010). Therefore, we testedCell 156, 413–427, January 30, 2014 ª2014 Elsevier Inc. 417
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Figure 3. DNA-Damage-Induced Golgi Dispersal Requires GOLPH3, MYO18A, and F-actin
(A) Knockdown in HeLa of GOLPH3 or MYO18A by each of three siRNA oligos (see Figure S3A) prevents CPT (1 mM)-induced Golgi dispersal. Cells were stained
with the indicated antibodies and DAPI (DNA).
(legend continued on next page)
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whether the Q at the +1 position (Q144) is required for the Golgi
to respond to DNA damage. First, we created a GOLPH3mutant,
TQ-AVQ, to test whether phosphorylation on T143 (but not T148)
is sufficient for DNA-damage-induced dispersal of the Golgi.
Indeed, in knockdown/rescue experiments, expression of the
siRNA-resistant TQ-AVQ mutant of GOLPH3 rescued Golgi
dispersal after DNA damage (Figures 4A and 4B). We also
created a mutant in which Q144 is mutated (TA-AVQ). This abol-
ishment of the TQ motif tests whether direct phosphorylation
by a DNA-damage-activated, TQ-directed kinase is required
for Golgi dispersal. In cells expressing the TA-AVQ mutant, the
Golgi failed to disperse after DNA damage (Figures 4A and 4B).
Finally, we created a phosphomimetic mutant (EA-AVQ) to serve
as a control to test whether the Q-to-A mutation nonspecifically
inactivates GOLPH3 or instead specifically impairs phosphory-
lation of GOLPH3 and therefore can be rescued by a phosphomi-
metic mutation that restores the electrostatic features of
phosphorylation. In fact, the Golgi dispersed normally after DNA
damage in cells expressing the EA-AVQ mutant (Figures 4A and
4B). We conclude that both T143 and Q144, which together
comprise the TQ motif, are both required for Golgi dispersal
in response to DNA damage. These data, together with the
requirement for DNA-PK but not other TQ-directed kinases,
strongly argue that DNA-PK directly phosphorylates GOLPH3.
Occasionally, the interaction between a kinase and its sub-
strate is sufficiently tight to allow direct observation by coim-
munoprecipitation (coIP) of a complex between them (Johnson
and Hunter, 2005). To test whether GOLPH3 and DNA-PK
form a stable complex, we immunoprecipitated endogenous
GOLPH3 from detergent lysates of HeLa cells. We used west-
ern blotting with an antibody specific to Ku80, a regulatory
subunit of DNA-PK, to determine whether the endogenous
DNA-PK complex was coimmunoprecipitated. As shown in
Figure 6D, in control IPs using preimmune serum, we see a
minimal background precipitation of Ku80. However, specific
IP of GOLPH3 is accompanied by significant coIP of Ku80,
but not other irrelevant proteins. This indicates a specific phys-
ical interaction between GOLPH3 and DNA-PK.
Thus, we observe that Golgi dispersal after DNA damage
requires both DNA-PK (which is known to be activated by
DNA damage; Neal and Meek, 2011) and the DNA-PK substrate
motif within GOLPH3. Our data also demonstrate that DNA-PK
can directly phosphorylate GOLPH3 on T143 in vitro, and we
detect a physical interaction between GOLPH3 and DNA-PK in
cells. Taken together, these results indicate that DNA-PK directly
phosphorylates GOLPH3 on T143, and that this is required for
Golgi dispersal in response to DNA damage.
DNA Damage Enhances the Interaction between
GOLPH3 and MYO18A
Since Golgi dispersal after DNA damage mimics Golgi dispersal
after overexpression of GOLPH3 (Ng et al., 2013), we infer that(B and C) Quantification of Golgi area for (A), with data pooled from two experim
(D) Treatment of HeLa with 10 mMLat B for 10 min reverses Golgi dispersal caused
expression of ManII-GFP, along with staining for F-actin (Cy5-phalloidin) and DN
(E) Quantification of Golgi area for (D); pooled from three experiments.
See also Figure S3.phosphorylation of GOLPH3 after DNA damage enhances the
function of GOLPH3. Therefore, we asked whether the response
to DNA damage enhances GOLPH3’s known interactions with
PtdIns(4)P or MYO18A. Interaction between GOLPH3 and
PtdIns(4)P is responsible for localization of the protein to the
trans-Golgi (Dippold et al., 2009; Wu et al., 2000). GOLPH3
localization to the Golgi is unchanged after DNA damage (Fig-
ures 3A, 4A, 5A, 6A, S1A, and S5A). Likewise, phosphorylation
mutants of GOLPH3 do not alter binding to PtdIns(4)P in vitro
(Figure S4E), and they localize to the Golgi in cells before and
after DNA damage (Figures 4A and S4A). Thus, phosphorylation
of GOLPH3 on T143/T148 in response to DNA damage does not
affect its binding to PtdIns(4)P.
Next, we determined whether DNA damage alters the strength
of the interaction between GOLPH3 andMYO18A. Indeed, X-ray
crystallographic models of GOLPH3 (Dippold et al., 2009;
Schmitz et al., 2008; Wood et al., 2009) indicate that T143 and
T148 are on the surface of GOLPH3 and would remain available
to interact with MYO18A even after GOLPH3 is bound to the
Golgi membrane. We assayed coIP of endogenous MYO18A
with GOLPH3 in detergent lysates from control cells or DNA-
damage-treated cells. DNA damage induced by either CPT or
DOXO led to enhanced interaction of GOLPH3 with MYO18A
(Figures 6E and S6B).
To determine whether phosphorylation of GOLPH3 directly
increases its affinity for MYO18A, we examined the interaction
of purified, bacterially expressed proteins, comparing WT
GOLPH3 (TQ-TVQ) with the phosphomimetic mutants (EQ-
EVQ and DQ-DVQ). As previously reported (Dippold et al.,
2009), WT GOLPH3 (but not the GST control) was specifically
pulled down with His-SUMO-MYO18A (aa 408–1,242), but not
with control His-SUMO alone (Figure 6F). Interestingly, we
observed that the phosphomimetic mutants had an increased
affinity for MYO18A, indicating that phosphorylation of
GOLPH3 alone is sufficient to increase its interaction with
MYO18A. We previously showed that GOLPH3/MYO18A/F-
actin applies a tensile force to the Golgi that assists in vesicu-
lation (Dippold et al., 2009; Ng et al., 2013). Taken together
with the observation that GOLPH3, MYO18A, and F-actin are
all required for Golgi dispersal in response to DNA damage,
we conclude that this enhanced interaction between GOLPH3
and MYO18A contributes to DNA-damage-induced Golgi
dispersal.
The DNA Damage Response Results in Impaired Golgi
Trafficking
The GOLPH3/MYO18A/F-actin pathway is critical for Golgi
to PM trafficking (Bishe´ et al., 2012; Dippold et al., 2009;
Ng et al., 2013). Therefore, we examined whether changes in
Golgi trafficking occur following DNA damage. Temperature-
sensitive, GFP-tagged ts045-VSVG-GFP synchronously traffics
from the ER through the Golgi to the PM upon a shift from aents. See Figures S3C and S3E for similar results in HEK293 and HUVECs.
by 1 mMCPT or 1.7 mMDOXO treatment for 17 hr. Golgi is marked by transient
A (DAPI). Time-lapse imaging of Lat B treatment is presented in Movie S3.
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Figure 4. DNA-Damage-Induced Golgi Dispersal Requires the GOLPH3 TQ Motif
(A) HeLa cells were transfected with GOLPH3 or control siRNA and 24 hr later were transiently transfected with the indicated GOLPH3 expression constructs.
For the final 24 hr, cells were treated with DMSO (control) or 1 mM CPT. Cells were stained with the indicated antibodies and DAPI (DNA). AQ-AVQ or TA-AVQ
mutants rescue the extended Golgi ribbon (see Figures S4A and S4B), but not DNA-damage-induced Golgi dispersal.
(B) Quantification of (A), pooled from six (top six) or three (bottom four) experiments.
See also Figure S4.restrictive (40C) to a permissive temperature (32C) (Presley
et al., 1997). In control cells, after the shift to 32C, we
observed trafficking from the ER through the Golgi to the PM
(Figures 6G and S6C). However, after 18 hr of CPT treatment,420 Cell 156, 413–427, January 30, 2014 ª2014 Elsevier Inc.ts045-VSVG-GFP instead accumulated at the Golgi without
progressing to the PM. We conclude that DNA-damage-
induced Golgi dispersal results in impaired Golgi to PM
trafficking.
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Figure 5. ATM Is Not Required for DNA-
Damage-Induced Golgi Dispersal
(A) A-T cells with or without reconstitution of
ATM expression were treated for 22.5 hr with
3.4 mMDOXOor DMSO (control) alone or with 10 mM
KU55933 or 10 mM NU7441. Cells were stained
with the indicated antibodies and DAPI (DNA).
(B) Western blot for ATM shows that A-T cells lack
ATM, whereas reconstituted cells express the pro-
tein. Blots are representative of three experiments.
(C) Quantification of relative Golgi area for (A). The
Golgi disperses regardless of the presence of ATM
or treatment with ATM inhibitor. By contrast, DNA-
PK inhibitor completely prevents DNA-damage-
induced Golgi dispersal.
See also Figure S5 and Movie S4.GOLPH3 and MYO18A Are Required for Normal Survival
after DNA Damage
GOLPH3 is an oncogene that is known to modulate growth
factor signaling through the mTOR pathway (Scott et al.,
2009), which is known to deliver survival signals (Laplante
and Sabatini, 2009; Myers and Cantley, 2010). To determine
whether the DNA-PK/GOLPH3/MYO18A pathway is function-
ally important following DNA damage, we examined whether
interference with the pathway affects survival following DNA
damage. First, we examined the influence of the pathway
on DNA-damage-induced apoptotic cell death. As expected,
treatment of HeLa cells with DOXO caused significant
apoptosis, as detected by western blot for CCasp-3
(Figure 7A). Depletion of either GOLPH3 or MYO18A by
siRNA led to dramatic enhancement of CCasp-3 production
after DNA damage, indicating that GOLPH3 and MYO18A
participate in a pathway that protects cells from apoptosis
following DNA damage. Likewise, HUVEC survival after treat-Cell 156, 413–42ment with CPT was significantly impaired
by knockdown of GOLPH3 or DNA-PK
(Figure S7A).
Next, we asked whether GOLPH3
or MYO18A contribute to the ability of
cells to survive and proliferate following
DNA damage. We used siRNA to tran-
siently knock down GOLPH3, MYO18A,
or DNA-PK, and measured clonogenic
survival after 24 hr of exposure to
increasing doses of DOXO. We compared
the number of colonies that arose from
knockdown cells with the number of
colonies derived from control cells.
Similar to what was observed in previous
studies (Blunt et al., 1995; Peng et al.,
2002), depletion of DNA-PK decreased
survival after DNA damage (Figure 7B).
Furthermore, transient knockdown of
GOLPH3 or MYO18A at the time of
DNA damage reduced survival by an
order of magnitude. Therefore, all of the
components of the DNA-PK/GOLPH3/MYO18A pathway are required for normal cell survival
following DNA damage.
GOLPH3 Overexpression Confers Resistance
to DNA-Damaging Agents
Because normal levels of GOLPH3 protect cells from DNA-
damaging agents, we wondered whether elevated levels of
GOLPH3, as found frequently in human cancers, might render
cells refractory to killing by DNA-damaging agents. Thus, we
engineered HeLa cells to allow for doxycycline-inducible over-
expression of GOLPH3 with GFP. When treated with limiting
concentrations of doxycycline, 20% of these cells coex-
pressed GOLPH3 and GFP (Figure S7B; data not shown).
Compared with DMSO treatment (vehicle control), brief CPT
treatment for 24 hr resulted in 31% enrichment of GFP-posi-
tive/GOLPH3-overexpressing cells (Figure 7C). This enrichment
is a consequence of expression of GOLPH3, as expression of
GFP alone results in no enrichment. To test whether the ability7, January 30, 2014 ª2014 Elsevier Inc. 421
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of GOLPH3 to confer a survival advantage following DNA dam-
age depends on its function at the Golgi, we examined the effect
of doxycycline-induced overexpression of GOLPH3-R90L, a
point mutant that is unable to bind PtdIns(4)P and thus unable
to localize to the Golgi (Dippold et al., 2009). As shown in
Figure 7C, cells overexpressing GOLPH3-R90L are not signifi-
cantly enriched following DNA damage.
To test the role of phosphorylation of GOLPH3 in conferring
a survival advantage, we compared cells that were transiently
transfected with IRES-GFP constructs to express WT GOLPH3
(TQ-TVQ), unphosphorylatable GOLPH3 (AQ-AVQ), or phospho-
mimetic GOLPH3 (DQ-DVQ). As shown in Figure 7D, cells
coexpressing WT GOLPH3 and GFP have a survival advantage
over nonexpressing cells when treated with CPT. By com-
parison, the unphosphorylatable mutant of GOLPH3 does not
confer a survival advantage, although the phosphomimetic
mutant does. Thus, overexpression of GOLPH3 confers a sur-
vival advantage after DNA damage, protecting cells from killing
by CPT. This function of GOLPH3 depends on binding to
PtdIns(4)P, and therefore its ability to function at the Golgi, and
on GOLPH3 phosphorylation on the DNA-PK site.
We next examined whether transient overexpression of
GOLPH3 during DNA damage results in enhanced long-term
cell survival, as measured by a clonogenic survival assay. Doxy-
cycline was applied to the inducible cell lines for 4 days and then
withdrawn to transiently raise the level of GOLPH3 (or GOLPH3-
R90L or GFP alone). On day 2, replicates were replated at low
density and treated with various concentrations of DOXO for
24 hr to assess clonogenic survival after 2 weeks. As shown in
Figure 7E, transient overexpression of GOLPH3 (Figure S7C)
at the time of a single round of DOXO treatment increased
clonogenic survival by as much as 4.3-fold in a doxycycline-
dose-dependent manner. By contrast, doxycycline-induced
overexpression of GOLPH3-R90L or GFP alone had no signifi-
cant effect on clonogenic survival after DOXO treatment (Figures
S7D and S7E). Therefore, overexpression of GOLPH3 enhances
the ability of cells to survive DNA damage, and this ability
depends on GOLPH3’s interaction with PtdIns(4)P and thus its
localization to the Golgi. Taken together with the requirement
for GOLPH3 in the Golgi response to DNA damage and itsFigure 6. DNA-PK Relays the DNA Damage Signal Directly to GOLPH3
(A) HeLa transfected with the indicated siRNAs and treated with either DMSO (c
DAPI (DNA).
(B) Quantification of (A). Knockdown of DNA-PK prevents CPT-induced Golgi d
HEK293 and HUVECs in Figures S3C and S3E.
(C) DNA-PK kinase assay with GST-GOLPH3 TQ-TVQ (WT) or AQ-AVQmutant, or
(D) IP of endogenous GOLPH3 from HeLa lysates specifically coimmunoprecipita
control proteins, as detected by western blot. Results in (C) and (D) are each rep
(E) CoIP/western blotting detects increased interaction betweenGOLPH3 (G3) and
blot, indicates relative amount of protein in the lysate for each IP. Quantification in
GOLPH3 after CPT; p < 0.02 by t test, pooled from six experiments. Similar resu
(F) Pull-down of purified 6xHis-SUMO and 6xHis-SUMO-tagged MYO18A moto
mutant). Compared with WT, DQ-DVQ enhances the GOLPH3/MYO18A interacti
p < 0.05 versus WT (by t test), pooled from five experiments. Vertical line indicat
(G) Trafficking of ts045-VSVG-GFP to the PM is significantly impaired in HeLa c
total VSVG-GFP expression (GFP signal per cell), measured at the nonpermissi
n = 16–45 per time point, pooled from two experiments. Example images are sh
See also Figure S6.direct phosphorylation by DNA-PK, our results demonstrate
that DNA damage signals directly to the Golgi via GOLPH3, a
pathway that we conclude is an important feature of the DNA
damage response.
DISCUSSION
A Novel Response to DNA Damage
Understanding the cellular response to DNA damage is crucial
for discerning the mechanisms by which many chemothera-
peutic agents kill cancer cells and the mechanisms of escape
from killing. Here, we demonstrate a previously poorly appreci-
ated feature of the DNA damage response, namely, a dramatic
reorganization of the Golgi. We observe that DNA damage
triggered by drugs or ionizing radiation causes the Golgi to
fragment and become dispersed throughout the cytoplasm.
Nevertheless, cis-, medial-, and trans-Golgi compartments
remain colocalized. Dispersal of the Golgi is observed in
many cell lines as well as in primary cells, indicating that it is
a ubiquitous feature of the DNA damage response in mamma-
lian cells. The response occurs quickly and is detectable within
4 hr after exposure to DNA-damaging agents, yet it also per-
sists for weeks after transient exposure to DNA-damaging
agents. This persistence could be due to the stability of a small
number of DNA breaks that continue to activate the pathway
(van Vugt and Yaffe, 2010) or it may indicate the existence of
a positive feedback loop that maintains the Golgi dispersal
once it is initiated.
DNA-Damage-Induced Golgi Dispersal Occurs
Independently of Apoptosis
The effect of DNA damage on the Golgi has been largely
neglected in the literature, with a few prior hints of an effect
generally being ascribed to a consequence of DNA-damage-
induced apoptosis (Chiu et al., 2002; Jung et al., 2006; Lane
et al., 2002; Mancini et al., 2000; Qian and Yang, 2009). The
induction of Golgi dispersal by even minimally toxic doses of
DNA-damaging agents, the continued apparent health of cells
observed by time-lapse microscopy, and the persistence of
the Golgi dispersal for weeks all demonstrate that the Golgito Trigger Golgi Dispersal
ontrol) or 1 mM CPT for 19 hr were stained with the indicated antibodies and
ispersal. Data pooled from two experiments. See similar results obtained in
with addition of 10 mMNU7441. Coomassie stain demonstrates equal loading.
tes the endogenous DNA-PK regulatory subunit Ku80, but not other irrelevant
resentative of three experiments.
MYO18A after 1 mMCPT for 18 hr versusDMSO control. Input, run on a parallel
dicates a 3.7 ± 0.7-fold increase (mean ± SEM) in association of MYO18A with
lts for DOXO are shown in Figure S6B.
r domain (aa 408–1,242) with a mixture of purified GST and GOLPH3 (WT or
on by 2.2 ± 0.4-fold, and EQ-EVQ enhances it by 1.9 ± 0.5-fold (mean ± SEM);
es omission of irrelevant intervening lanes.
ells after 1 mM CPT for 18 hr. Quantification of surface VSVG-GFP relative to
ve temperature (time = 0) or after shift to the permissive temperature (32C);
own in Figure S6C.
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Figure 7. GOLPH3 and MYO18A Modulate Survival after DNA Damage
(A) Knockdown of GOLPH3 or MYO18A increases apoptosis after DNA damage. HeLa cells transfected with the indicated siRNAs after 48 hr were treated with
2 mM DOXO for 24 hr. Cell lysates were blotted for CCasp-3 to detect apoptosis. Results are representative of four experiments.
(B) Clonogenic survival assay of HeLa cells transfected with the indicated siRNAs. Forty-eight hours after siRNA transfection, the cells were replated to produce
countable numbers of colonies and then treated with the indicated concentrations of DOXO for 24 hr. Colonies were counted 10–14 days later. Graphed is the
mean ± SEM relative to no treatment. Data are pooled from two (MYO18A siRNA) or three (Control, GOLPH3, and DNA-PK siRNA) experiments, each done in
triplicate (n = 6 or 9).
(C) HeLa cell lines were treated with doxycycline to induce overexpression of GFP and GOLPH3, as indicated, in a fraction of cells (western blot shown in
Figure S7B), and then treated with 1 mMCPT or DMSO (control) for 24 hr to assess the survival advantage of GFP+ cells. Graphed is the increase in the proportion
of GFP+ cells that survived after CPT treatment relative to after DMSO treatment. Data are pooled from three experiments, each done in quadruplicate (n = 12).
(legend continued on next page)
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response is unrelated to apoptosis. Furthermore, inhibition
of apoptosis does not impair DNA-damage-induced Golgi
dispersal. Perhaps most significantly, we identify a direct
signaling pathway from DNA-PK, a DNA-damage-activated
kinase, to the Golgi protein GOLPH3, demonstrating that no
intermediate steps are required at all. Finally, we find that
rather than being a by-product of cell death, the pathway that
is responsible for Golgi dispersal after DNA damage functions
to enable cell survival after DNA damage.
DNA Damage Signals to the Golgi to Enhance Survival
The alteration in Golgi morphology after DNA damage leads
ultimately to impairment of trafficking from the Golgi to the PM.
However, the DNA damage response could conceivably involve
initially an increase in delivery of cargoes to the PM, analogous
to the effect proposed for the consequence of loss of GOLPH3L,
the endogenous inhibitor of GOLPH3 that is expressed in highly
secretory cells (Ng et al., 2013). In any case, we suspect that
there exist one or more cargoes that depend on appropriate
trafficking in order to influence cell death or survival, and that
altered trafficking of these cargoes following DNA damage
results in enhanced cell survival. The observation that the
GOLPH3 TQ site and DNA-PK are both restricted to higher
multicellular organisms may indicate a role in balancing cell
survival with organismal survival.
Implications for Cancer Prognostics and Therapeutics
Previous studies have noted that a high proportion of human
cancers harbor amplification and overexpression of GOLPH3
(Hu et al., 2013; Hua et al., 2012; Kunigou et al., 2011; Li
et al., 2012, 2011; Scott et al., 2009; Wang et al., 2012; Zeng
et al., 2012; Zhou et al., 2012). These studies reported that
overexpression of GOLPH3 correlates with a poor prognosis
for several cancers, a finding that generally suggests that the
cancers progress despite treatment with standard chemother-
apeutics. Strikingly, we find that overexpression of GOLPH3
confers resistance to killing by DNA-damaging agents. Since
DNA-damaging agents remain the mainstay of many cancer
treatment regimens (Azzoli et al., 2011; Swain, 2011), this raises
the possibility that GOLPH3 may be a clinically relevant marker
of responsiveness to chemotherapy. Conversely, we find that
interference with the GOLPH3/MYO18A pathway significantly
impairs cell survival after DNA damage, suggesting that
small-molecule inhibitors of the pathway may have therapeutic
utility. In any case, the Golgi response to DNA damage repre-
sents a newly appreciated, fundamental aspect of cell biology
that advances our understanding of the cellular response
to DNA damage and reveals a direct path to the Golgi via
DNA-PK and GOLPH3.(D) HeLa survival after DNA damage with transient overexpression of GOLPH3-I
of GFP+ cells that survived after 1 mM CPT treatment relative to after DMSO trea
(n = 35 or 36).
(E) Clonogenic survival assay of HeLa cell lines expressing doxycycline-induci
of doxycycline (western blot shown in Figure S7C), and then replated and treated
from three (150 ng/ml doxy) to five (0 and 500 ng/ml doxy) experiments, each done
4.3-fold, whereas overexpression of IRES-GFP or GOLPH3-R90L-IRES-GFP had
See also Figure S7.EXPERIMENTAL PROCEDURES
Kinase Assay
Kinase reactions were performed according to the DNA-PK supplier (Prom-
ega) with 1 mCi [g-32P]-ATP (Perkin Elmer). Reactions were incubated at
30C for 30 min, stopped by the addition of boiling SDS sample buffer, run
on SDS-PAGE, and visualized with a PhosphorImager (Molecular Dynamics).
Clonogenic Survival
HeLa cells were treated as described in the figure legends, replated as a dilu-
tion series, and then treated with the indicated concentrations of DOXO for
24 hr. Colonies were counted 10–14 days later.
Fluorescence Microscopy
Fluorescence microscopy was performed with an Olympus IX81-ZDC spin-
ning-disk confocal microscope and analyzed using Slidebook and ImageJ
software.
Measurement of Golgi Area
Immunofluorescent images of cells stained with a Golgi marker were
measured either by manual demarcation of the Golgi with a limiting polygon
and calculation of its area using ImageJ or by automated identification of the
Golgi and calculation of the area of the smallest encircling ellipse as performed
by CellProfiler (Carpenter et al., 2006). Both methods produced similar results.
IPs and Pull-Downs
IPs and pull-downs were performed as described previously (Dippold et al.,
2009). For IP, cells were lysed in buffer containing 10 mM CHAPS. Lysates
were precleared and incubated with anti-GOLPH3 or preimmune serum,
bound to Protein A Sepharose (GE Healthcare), washed extensively, and
eluted by boiling in SDS sample buffer. Briefly, for the pull-downs, 6xHis-
SUMO and 6xHis-SUMO-tagged MYO18A motor domain (aa 408-1242) ex-
pressed in E. coli were bound to Ni-NTA-agarose beads (QIAGEN) and
washed. A 1:1mixture of purified GST andGOLPH3 (WT ormutant) was added
to the protein-bound beads at a 1:4 molar ratio of GST/GOLPH3:6xHis-SUMO
or 6xHis-SUMO-MYO18Amotor domain and rotated 2 hr at 4C in 10mMNa2-
HPO4, 150 mM NaCl, 20 mM imidazole, and 10 mM CHAPS (pH 7.4), followed
by washing and elution in boiling SDS sample buffer for western blotting.
Mass Spectrometry
Bands were excised from polyacrylamide stained with SafeStain SimplyBlue
(Invitrogen), subjected to in-gel digestion, and analyzed as described previ-
ously (Zhou et al., 2004).
Lipid Blots
Lipid blots were performed as described previously (Dippold et al., 2009). Pos-
itive controls were tested in parallel.
For further details regarding the methods and materials used in this work,
see the Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and four movies and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2013.12.023.RES-GFP or controls, as indicated. Graphed is the increase in the proportion
tment. Data are pooled from three experiments, each with four to 16 replicates
ble GOLPH3-IRES-GFP. Cells were treated with the indicated concentration
with DOXO for 24 hr. Colonies were counted 13 or 14 days later. Data pooled
in triplicate (n = 9 or 15). Overexpression of GOLPH3 increased cell survival by
no effect on clonogenic survival after DNA damage (Figures S7D and S7E).
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